Enhanced immune response to T-independent antigen by using CpG oligodeoxynucleotides encapsulated in liposomes

By Li W.M.   Bally M.B.   Schutze-Redelmeier M.-P.  

Vaccine, Vol. 20, Iss. 1, 2001-10 ,pp. : 148-157

Elsevier

Access to resources Recommend Favorite

Synthetic oligodeoxynucleotides containing CpG motifs enhance immunogenicity of a peptide malaria vaccine in Aotus monkeys

By Jones T.R.   Obaldia N.   Gramzinski R.A.   Charoenvit Y.   Kolodny N.   Kitov S.   Davis H.L.   Krieg A.M.   Hoffman S.L.  

Vaccine, Vol. 17, Iss. 23, 1999-08 ,pp. : 3065-3071

Elsevier

Access to resources Recommend Favorite

Induction of protective immunity in pigs after immunisation with CpG oligodeoxynucleotides formulated in a lipid-based delivery system (Biphasix&unknown;)

By Alcon V.L.   Foldvari M.   Snider M.   Willson P.   Gomis S.   Hecker R.   Babiuk L.A.   Baca-Estrada M.E.  

Vaccine, Vol. 21, Iss. 17, 2003-05 ,pp. : 1811-1814

Elsevier

Access to resources Recommend Favorite

Immunological monitoring during therapeutic vaccination as a prerequisite for the design of new effective therapies: induction of a vaccine-specific CD4+ T-cell proliferative response in chronic hepatitis B carriers

By Jung M.-C.   Gruner N.   Zachoval R.   Schraut W.   Gerlach T.   Diepolder H.   Schirren C.-A.   Page M.   Bailey J.   Birtles E.   Whitehead E.   Trojan J.   Zeuzem S.   Pape G.R.  

Vaccine, Vol. 20, Iss. 29, 2002-10 ,pp. : 3598-3612

Elsevier

Access to resources Recommend Favorite

Dendritic cell KLH loading requirements for efficient CD4 + T-cell priming and help to peptide-specific cytotoxic T-cell response, in view of potential use in cancer vaccines

By Millard A.L.   Ittelet D.   Schooneman F.   Bernard J.  

Vaccine, Vol. 21, Iss. 9, 2003-02 ,pp. : 869-876

Elsevier

Access to resources Recommend Favorite